= Members Only
Educational Webinars
ACT sponsors quarterly webinars on current topics in toxicology, including primarily drug and chemical safety assessments. Presenters are experts in their field, with backgrounds in government, industry or academia. The goal of the webinar series is to provide accessible education on topics in toxicology to ACT members and, more broadly, members of the toxicology community worldwide. ACT Webinars are reaching thousands, with collaborations spanning the globe while increasing individual and corporate ACT membership and participation. The ACT Signature Webinars are approximately 90 minutes, which includes questions and answers.
Upcoming Webinar
Safety Assessment of Metabolites in Drug Development: Current PerspectiveHosted by American College of ToxicologySupported by Society of Toxicologic Pathology and Safety Pharmacology Society Moderated by Kara Polhamus and Sam Tadepalli Date and Time: February 12, 2020 at 11:00 am (EST) Description: This webinar will provide an overview of safety assessment of metabolites in drug development. The speaker will discuss relevant guidance documents and will describe important considerations for the safety assessment of drug metabolites, including type of studies required and timing of submission to regulatory Agencies. This topic has evolved over the last few years and the speaker will incorporate FDA recent case studies that will provide participants insight into the regulatory decision-making process regarding this topic. Examples will include unique human metabolites, disproportionate human metabolites, metabolites that are acyl glucuronides, and examples of safety assessment of drug metabolites for severe, debilitating, and life-threatening (SDLT) conditions. |
Speaker: Carol M. Galvis, PhDThere is no fee but advanced registration is required.
Archives/Past Webinars
View ACT’s Past Signature Webinars ▸
Scientific Liaison Coalition (SLC) Webinars
Tel: 703.547.0875 | Fax: 703.438.3113 | Email: acthq@actox.org
You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | Provide Consent | Unsubscribe